Aligos Therapeutics (ALGS) News Today $13.75 -0.73 (-5.04%) (As of 08/21/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 Time Period August 21 at 1:57 PM | marketbeat.comAligos Therapeutics (NASDAQ:ALGS) Shares Down 5.7% Aligos Therapeutics (NASDAQ:ALGS) Trading Down 5.7%August 21 at 7:16 AM | americanbankingnews.comAligos Therapeutics (NASDAQ:ALGS) Shares Gap Up to $13.13August 21 at 3:05 AM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS)August 20 at 7:12 PM | marketbeat.comAligos Therapeutics (NASDAQ:ALGS) Shares Up 4.2%Aligos Therapeutics (NASDAQ:ALGS) Trading Up 4.2%August 20 at 8:27 AM | msn.comHC Wainwright & Co. Initiates Coverage of Aligos Therapeutics (ALGS) with Buy RecommendationAugust 19 at 7:24 AM | americanbankingnews.comAligos Therapeutics (NASDAQ:ALGS) Coverage Initiated by Analysts at HC WainwrightAugust 18, 2024 | ca.finance.yahoo.com5WK.SG,0P0001LPS2,0 (5WK.SG)August 18, 2024 | ca.finance.yahoo.comAligos Therapeutics Inc (5WK.DU)August 17, 2024 | americanbankingnews.comAligos Therapeutics (NASDAQ:ALGS) Shares Scheduled to Reverse Split on Monday, August 19thAugust 17, 2024 | americanbankingnews.comAligos Therapeutics Stock Scheduled to Reverse Split on Monday, August 19th (NASDAQ:ALGS)August 15, 2024 | ca.finance.yahoo.comOXO.SG,0P0000BSRG,0 (OXO.SG)August 15, 2024 | globenewswire.comAligos Therapeutics Announces Reverse Stock SplitAugust 8, 2024 | globenewswire.comAligos Therapeutics Strengthens Board with Two New Independent DirectorsAugust 6, 2024 | tmcnet.comAligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial ResultsJuly 29, 2024 | finance.yahoo.comCompanies Like Aligos Therapeutics (NASDAQ:ALGS) Could Be Quite RiskyJuly 22, 2024 | globenewswire.comAligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.July 10, 2024 | globenewswire.comAligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHBJune 5, 2024 | globenewswire.comAligos Therapeutics Presents Positive Data at the EASL Congress 2024May 22, 2024 | globenewswire.comAligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024May 21, 2024 | globenewswire.comAligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASHMay 17, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Aligos Therapeutics (ALGS)May 13, 2024 | marketbeat.comAligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Up 27.6% in AprilAligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 838,500 shares, a growth of 27.6% from the April 15th total of 657,200 shares. Based on an average trading volume of 388,000 shares, the days-to-cover ratio is currently 2.2 days.May 10, 2024 | marketbeat.comLeerink Partnrs Weighs in on Aligos Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ALGS)Aligos Therapeutics, Inc. (NASDAQ:ALGS - Free Report) - Analysts at Leerink Partnrs increased their Q2 2024 earnings per share (EPS) estimates for Aligos Therapeutics in a report issued on Tuesday, May 7th. Leerink Partnrs analyst R. Ruiz now expects that the company will post earnings per shareMay 10, 2024 | markets.businessinsider.comHold Rating on Aligos Therapeutics Amidst Clinical Trials and Financial StabilityMay 9, 2024 | finance.yahoo.comAligos Therapeutics First Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.54 loss in 1Q 2023)May 7, 2024 | investorplace.comALGS Stock Earnings: Aligos Therapeutics Misses EPS for Q1 2024May 7, 2024 | finance.yahoo.comAligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial ResultsMay 7, 2024 | finance.yahoo.comAligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial ResultsMay 1, 2024 | marketbeat.comAligos Therapeutics (ALGS) Set to Announce Quarterly Earnings on TuesdayAligos Therapeutics (NASDAQ:ALGS) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.April 30, 2024 | finance.yahoo.comAligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024April 27, 2024 | marketbeat.comShort Interest in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Decreases By 24.4%Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) saw a significant decrease in short interest in April. As of April 15th, there was short interest totalling 657,200 shares, a decrease of 24.4% from the March 31st total of 868,800 shares. Based on an average daily volume of 388,300 shares, the short-interest ratio is presently 1.7 days.April 25, 2024 | globenewswire.comAligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 StudyApril 25, 2024 | finance.yahoo.comAligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MDApril 9, 2024 | finance.yahoo.comAligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024April 3, 2024 | finance.yahoo.comAligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH SubjectsMarch 27, 2024 | globenewswire.comAligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 StudiesMarch 16, 2024 | uk.investing.comAligos Therapeutics Inc (ALGS)March 15, 2024 | markets.businessinsider.comMaintaining a Hold: Balancing Promise and Risk in Aligos Therapeutics’ Clinical PipelineMarch 14, 2024 | finance.yahoo.comAligos Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 12, 2024 | benzinga.comRecap: Aligos Therapeutics Q4 EarningsMarch 12, 2024 | markets.businessinsider.comAligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | globenewswire.comAligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial ResultsMarch 8, 2024 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Aligos Therapeutics (ALGS)March 6, 2024 | seekingalpha.comTracking Baker Brothers Portfolio - Q4 2023 UpdateMarch 6, 2024 | marketbeat.comAligos Therapeutics (ALGS) Set to Announce Earnings on TuesdayAligos Therapeutics (NASDAQ:ALGS) will be releasing earnings after the market closes on Tuesday, March 12, Zacks reports.March 5, 2024 | globenewswire.comAligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024February 26, 2024 | globenewswire.comAligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024February 24, 2024 | msn.comAligos Therapeutics (ALGS) Price Target Increased by 300.00% to 4.08February 23, 2024 | benzinga.comAligos Therapeutics Stock (NASDAQ:ALGS) Earnings Dates and Earning CallsFebruary 23, 2024 | benzinga.comAligos Therapeutics Stock (NASDAQ:ALGS), Short Interest Report Get Aligos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump is sounding the alarm (Ad)Europe is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail". Are you prepared? Click here to get your complimentary retirement guide! ALGS Media Mentions By Week ALGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALGS News Sentiment▼0.190.44▲Average Medical News Sentiment ALGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALGS Articles This Week▼141▲ALGS Articles Average Week Get Aligos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Dynavax Technologies News Today Arbutus Biopharma News Today Assembly Biosciences News Today Ultragenyx Pharmaceutical News Today Avidity Biosciences News Today Crinetics Pharmaceuticals News Today ADMA Biologics News Today Dyne Therapeutics News Today TG Therapeutics News Today Biohaven News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALGS) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe #1 A.I. Crypto You Don’t Own (YET!)Markets are volatile right now—stocks, cryptos, you name it. But here's a crucial fact everyone is missing:...Crypto 101 Media | SponsoredYou’ve been lied to for 615 days, and countingAll of the hype around artificial intelligence has been nothing but an artificial illusion…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
